Differences in Synovial Cytokine Profile Associated with Long-Term Clinical Outcomes in Patients with Knee Osteoarthritis Undergoing Corrective Osteotomy with Platelet-Rich Plasma or Stromal Vascular Fraction Post-Treatments.
Aleksey PrizovElena TchetinaIlya EreminNikolay ZagorodniyAndrey PulinEvgeniy BelyakEvgeniy GoncharovKonstantin KotenkoIvan SmyshlyaevSvetlana I GlukhovaAleksandr LilaPublished in: International journal of molecular sciences (2022)
Functional outcomes and synovial fluid (SF) cytokine concentrations in response to platelet-rich plasma (PRP) or stromal vascular fraction (SVF) post-treatments following open wedge high tibial osteotomy (HTO) in 20 patients with knee osteoarthritis (OA) were examined. Six weeks after surgery, the knees of 10 patients were injected with autologous PRP (PRP subgroup), while another 10 patients were injected with autologous SVF (SVF subgroup) and monitored for 1.5 years. Pain assessment (VAS score) and functional activity (KOOS, KSS, Outerbridge, and Koshino scores) were applied. PRP subgroup performed better compared with the SVF subgroup according to KOOS, KSS, and VAS scores, while the SVF subgroup demonstrated better results according to Outerbridge and Koshino testing and produced more pronounced cartilage regeneration in the medial condyle and slowed down cartilage destruction in its lateral counterpart. SF was collected before and one week after PRP or SVF injections and tested for concentrations of 41 cytokines (Multiplex Assay). In the PRP subgroup, a significant decrease in IL-6 and CXCL10 synovial concentrations was accompanied by an increase in IL-15, sCD40L, and PDGF-AB/BB amounts. The SVF subgroup demonstrated a significant decrease in synovial TNFα, FLT-3L, MIP-1β, RANTES, and VEGF concentrations while SF concentrations of MCP-1 and FGF2 increased. Both post-treatments have a potential for increased tissue regeneration, presumably due to the downregulation of inflammation and augmentation of synovial growth factor concentrations.
Keyphrases
- platelet rich plasma
- knee osteoarthritis
- growth factor
- end stage renal disease
- phase iii
- stem cells
- newly diagnosed
- ejection fraction
- bone marrow
- total knee arthroplasty
- rheumatoid arthritis
- randomized controlled trial
- high throughput
- chronic pain
- signaling pathway
- oxidative stress
- mesenchymal stem cells
- pain management
- cell proliferation
- spinal cord
- neuropathic pain
- tyrosine kinase
- angiotensin ii
- vascular endothelial growth factor
- endothelial cells
- gestational age
- wound healing
- recombinant human
- anterior cruciate ligament